Elekta Radiosurgery Solutions are Creating New Possibilities for the Most Challenging Cases of the Hea...(w neurosurgery and oncology. Acc...),Health

According to President and CEO of Elekta North America, Joseph K. Jachinowski, "Since its very foundation, Elekta has sought to develop technology that allowed practitioners to achieve specific clinical objectives. Today Elekta Neuroscience is still developing technology to address the most challenging cases in neurosurgery and oncology, creating new treatment possibilities that are redefining what we call, human care."

*Extend requires 510(k) review and is not yet commercially available in the U.S.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated state of the art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.